BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24389438)

  • 61. Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus.
    Fahn HJ; Wang LS; Huang BS; Huang MH; Chien KY
    Ann Thorac Surg; 1994 Mar; 57(3):677-81. PubMed ID: 8147640
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
    Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
    Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of one-year endoscopic follow-up for the esophageal remnant and gastric conduit after esophagectomy with gastric reconstruction for esophageal squamous cell carcinoma.
    Park SY; Lee HS; Jang HJ; Lee JY; Joo J; Zo JI
    Yonsei Med J; 2013 Mar; 54(2):381-8. PubMed ID: 23364971
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of tumor length on survival for patients with resected esophageal cancer.
    Mirinezhad SK; Jangjoo AG; Seyednejad F; Naseri AR; Mohammadzadeh M; Nasiri B; Eftekharsadat AT; Farhang S; Somi MH
    Asian Pac J Cancer Prev; 2014; 15(2):691-4. PubMed ID: 24568480
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
    Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
    Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Patterns and time of recurrence after complete resection of esophageal cancer.
    Sugiyama M; Morita M; Yoshida R; Ando K; Egashira A; Takefumi O; Saeki H; Oki E; Kakeji Y; Sakaguchi Y; Maehara Y
    Surg Today; 2012 Aug; 42(8):752-8. PubMed ID: 22370963
    [TBL] [Abstract][Full Text] [Related]  

  • 67. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma?
    Hu Y; Hu C; Zhang H; Ping Y; Chen LQ
    Ann Surg Oncol; 2010 Mar; 17(3):784-90. PubMed ID: 19953333
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinicopathological Features of Cervical Esophageal Cancer: Retrospective Analysis of 63 Consecutive Patients Who Underwent Surgical Resection.
    Saeki H; Tsutsumi S; Yukaya T; Tajiri H; Tsutsumi R; Nishimura S; Nakaji Y; Kudou K; Akiyama S; Kasagi Y; Nakashima Y; Sugiyama M; Sonoda H; Ohgaki K; Oki E; Yasumatsu R; Nakashima T; Morita M; Maehara Y
    Ann Surg; 2017 Jan; 265(1):130-136. PubMed ID: 28009737
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Esophageal cancer: outcome according to therapeutic strategy].
    Rousseau D; Capitain O; Denis F; Girault S; Poirier AL; Paumier A; Cellier P; Hamy A; Mahé MA; Mesgouez-Nebout N
    Cancer Radiother; 2013 Feb; 17(1):10-20. PubMed ID: 23270680
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
    Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
    Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
    World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection.
    Hsu PK; Wang BY; Huang CS; Wu YC; Hsu WH
    J Gastrointest Surg; 2011 Apr; 15(4):558-65. PubMed ID: 21327531
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low expression of claudin-4: an indicator of recurrence in esophageal squamous cell carcinoma after Ivor Lewis esophagectomy?
    Shi M; Wang Z; Song L; Wang D; Sun Z
    Med Oncol; 2014 May; 31(5):951. PubMed ID: 24737010
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.
    Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR
    Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Newly developed primary malignancies in long-term survivors who underwent curative esophagectomy for squamous cell carcinoma of the esophagus.
    Shimizu D; Koike M; Kanda M; Sonohara F; Hattori N; Hayashi M; Tanaka C; Yamada S; Kodera Y
    Surg Today; 2021 Jan; 51(1):153-158. PubMed ID: 32638131
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patterns of lymph node recurrence after radical surgery impacting on survival of patients with pT1-3N0M0 thoracic esophageal squamous cell carcinoma.
    Chen XL; Chen TW; Fang ZJ; Zhang XM; Li ZL; Li H; Tang HJ; Zhou L; Wang D; Zhang Z
    J Korean Med Sci; 2014 Feb; 29(2):217-23. PubMed ID: 24550648
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
    Chen G; Wang Z; Liu XY; Liu FY
    Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Surveillance Implications of Recurrence Patterns in Early Node-Negative Esophageal Adenocarcinoma.
    Nobel TB; Livschitz J; Xing XX; Barbetta A; Hsu M; Tan KS; Sihag S; Jones DR; Molena D
    Ann Thorac Surg; 2019 Dec; 108(6):1640-1647. PubMed ID: 31323215
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Patterns of surveillance following curative intent therapy for gastroesophageal cancer.
    Peixoto RD; Lim HJ; Kim H; Abdullah A; Cheung WY
    J Gastrointest Cancer; 2014 Sep; 45(3):325-33. PubMed ID: 24756830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.